Financhill
Buy
64

DMAC Quote, Financials, Valuation and Earnings

Last price:
$8.80
Seasonality move :
25.24%
Day range:
$8.61 - $8.96
52-week range:
$3.19 - $9.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.86x
Volume:
240.8K
Avg. volume:
437.5K
1-year change:
63.5%
Market cap:
$457.2M
Revenue:
--
EPS (TTM):
-$0.72

Earnings Data

Next earnings date for DMAC
Mar 17
2026
Most recent earnings per share
-$0.17
Missed by $0.01
(Nov 12/2025)
Consensus Estimate
-$0.16
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DMAC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/17/2026 Q4 -- -- -- -$0.18 --
11/12/2025 Q3 -- -- -$0.17 -$0.16 -$0.01
08/12/2025 Q2 -- -- -$0.18 -$0.19 $0.01
05/08/2025 Q1 -- -- -$0.18 -$0.18 $0.00
03/18/2025 Q4 -- -- -$0.18 -$0.17 -$0.01
11/13/2024 Q3 -- -- -$0.15 -$0.16 $0.01
08/07/2024 Q2 -- -- -$0.13 -$0.16 $0.02
05/09/2024 Q1 -- -- -$0.14 -$0.16 $0.02
03/20/2024 Q4 -- -- -$0.14 -$0.14 $0.00
11/13/2023 Q3 -- -- -$0.12 -$0.13 $0.01
08/14/2023 Q2 -- -- -$0.16 -- --
05/15/2023 Q1 -- -- -$0.20 -- --
03/28/2023 Q4 -- -- -$0.14 -- --
11/09/2022 Q3 -- -- -$0.12 -- --
08/10/2022 Q2 -- -- -$0.13 -- --
05/04/2022 Q1 -- -- -$0.13 -- --
03/14/2022 Q4 -- -- -$0.12 -- --
11/10/2021 Q3 -- -- -$0.18 -- --
08/11/2021 Q2 -- -- -$0.17 -- --
05/05/2021 Q1 -- -- -$0.19 -- --
03/10/2021 Q4 -- -- -$0.22 -- --
11/04/2020 Q3 -- -- -$0.19 -- --
08/11/2020 Q2 -- -- -$0.18 -- --
05/13/2020 Q1 -- -- -$0.19 -- --
03/23/2020 Q4 -- -- -$0.21 -- --
11/13/2019 Q3 -- -- -$0.20 -- --
08/13/2019 Q2 -- -- -$0.21 -- --
05/13/2019 Q1 -- -- -$0.27 -- --
03/19/2019 Q4 -- -- -- -- --
09/30/2018 Q3 -- $500K -$0.18 -- --
06/30/2018 Q2 -- -- -$0.22 -- --
03/31/2018 Q1 -- -- -$0.10 -- --
12/31/2017 Q4 -- -- -$0.20 -- --
09/30/2017 Q3 -- -- -$0.20 -- --
06/30/2017 Q2 -- -- -$0.20 -- --
03/31/2017 Q1 -- -- -$0.20 -- --
12/31/2016 Q4 -- -- -- -- --
09/30/2016 Q3 -- -- -$0.15 -- --
06/30/2016 Q2 -- -- -$0.16 -- --
03/31/2016 Q1 -- -- -$0.15 -- --
12/31/2015 Q4 -- -- -$0.13 -- --

DiaMedica Therapeutics, Inc. Earnings Questions

  • How Much did DiaMedica Therapeutics, Inc. Generate in Revenue Last Quarter?

    DiaMedica Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did DiaMedica Therapeutics, Inc. Beat Earnings Last Quarter?

    DiaMedica Therapeutics, Inc. announced earnings per share of -$0.17 which represents a miss of analyst forecast a -$0.16 per share.

  • Is DiaMedica Therapeutics, Inc. Profitable?

    DiaMedica Therapeutics, Inc. reported -$18K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for DiaMedica Therapeutics, Inc. EPS Next Year?

    DiaMedica Therapeutics, Inc.'s earnings are forecast to decrease from -$0.61 per share to -$0.59 per share next year representing a decrease of -18.6%.

  • When is DiaMedica Therapeutics, Inc.'s Earnings Date?

    DiaMedica Therapeutics, Inc.'s next earnings date is March 17, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock